Lifitegrast

Common brands: Xiidra, Vitamin D, Restasis, Acid Reducer, Oxervate

Top reporter: Bausch & Lomb Incorporated

Lymphocyte Function-Associated Antigen-1 Antagonist [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Calcineurin Inhibitor Immunosuppressant [EPC]Provitamin D2 Compound [EPC]Corticosteroid [EPC]
16,017
Total Reports
7,025
Serious Reports
286
Death Reports
30
Reported Reactions
Death Report Ratio: Moderate (1.79%)

Patient Demographics

Male
2,478
Female
11,956

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Lifitegrast.

# Reaction Reports % of Total
1 EYE IRRITATION 2,706
12.8%
2 VISION BLURRED 2,610
12.4%
3 DRUG INEFFECTIVE 1,568
7.4%
4 EYE PAIN 1,405
6.7%
5 INSTILLATION SITE PAIN 1,283
6.1%
6 DRY EYE 1,146
5.4%
7 DYSGEUSIA 1,095
5.2%
8 INSTILLATION SITE REACTION 1,019
4.8%
9 OCULAR HYPERAEMIA 679
3.2%
10 LACRIMATION INCREASED 614
2.9%
11 HEADACHE 609
2.9%
12 VISUAL IMPAIRMENT 572
2.7%
13 PRODUCT DOSE OMISSION ISSUE 443
2.1%
14 EYE PRURITUS 429
2.0%
15 EYE DISCHARGE 384
1.8%
16 HYPERSENSITIVITY 369
1.8%
17 PRODUCT QUALITY ISSUE 364
1.7%
18 PRODUCT USE COMPLAINT 364
1.7%
19 PAIN 344
1.6%
20 EYE DISORDER 330
1.6%
21 OFF LABEL USE 318
1.5%
22 NAUSEA 298
1.4%
23 BURNING SENSATION 289
1.4%
24 DIZZINESS 268
1.3%
25 EYE SWELLING 268
1.3%
26 CONDITION AGGRAVATED 264
1.3%
27 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 264
1.3%
28 PRODUCT CONTAINER ISSUE 259
1.2%
29 DEATH 255
1.2%
30 OCULAR DISCOMFORT 250
1.2%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.